STAAR Surgical STAA
STAAR Surgical Q2 FY24: revenue $99.0M; diluted EPS $0.15
- Form
- 10-Q
- Filed
- Period
- Importance
- Notable
- Accession
- 0000950170-24-092753
- Document
- 10-Q
Key figures from this report
These are the numbers STAAR Surgical reported for Q2 FY24, the quarter ended Jun 28, 2024, as tagged in the filing’s XBRL data, each against the same quarter a year earlier. A plain-English reading of this report is not written yet.
- Revenue$99.0MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Net income$7.4MNo year-earlier figure tagged10-Q income statement, on EDGAR
- Diluted EPS$0.15No year-earlier figure tagged10-Q income statement, on EDGAR
- Cash and cash equivalents$192.8MNo year-earlier figure taggedCash and equivalents only; the company page adds short-term investments.10-Q balance sheet, on EDGAR
- Cash from operations−$10.4MNo year-earlier figure tagged10-Q cash flow statement, on EDGAR; the filing reports year-to-date cash flows; this quarter is the year-to-date total less the earlier quarters
Similar companies
Companies of similar size in SIC 3851 and related industry codes: the same peer list as the financial tables.
- National Vision Holdings EYE public float $1.3B, Jun 28, 2025
- Bausch & Lomb BLCO public float $557M, Jun 30, 2025
- RxSight RXST public float $504M, Jun 30, 2025
- Warby Parker WRBY public float $2.2B, Jun 30, 2025
